of their dangerous side effects under a program known as Risk Evaluation and Mitigation System, REMS.", "type": "text"}, {"components": [{"caption": "Elaine Kodish, who lives in Los Angeles, said she pays $785 a month for Revlimid, a drug produced by Celgene that helps treat her multiple myeloma. Emily Berl for